The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Autologous Transfusion Products Market Research Report 2025
Synopsis
Autologous Transfusion Products are products that collect, process and preserve a patient's own blood for use in situations where a patient requires transfusion during surgery or other medical procedures. Compared with traditional donor blood, autologous blood transfusion products can avoid potential risks such as infection and immune reaction transmitted by donor blood, and can also reduce problems such as shortage of donor blood and cost of donor blood.
Global Autologous Transfusion Products market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Autologous Transfusion Products market research.
Key manufacturers engaged in the Autologous Transfusion Products industry include LivaNova, Haemonetics, Getinge AB, Medtronic, Terumo, Braile Biomedica, Fresenius Kabi, Appligent and Wandong Health Sources, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Autologous Transfusion Products were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Autologous Transfusion Products market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Autologous Transfusion Products market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
LivaNova
Haemonetics
Getinge AB
Medtronic
Terumo
Braile Biomedica
Fresenius Kabi
Appligent
Wandong Health Sources
Advancis Surgical
Macopharma SA
Asahi Kasei Medical
Stryker Corporation
Zimmer Biomet Holdings
Segment by Type
Intraoperative Autologous Transfusion Products
Postoperative Autologous Transfusion Products
Dual Mode Autologous Transfusion Products
Segment by Application
Organ Transplant Surgery
Orthopedic Surgery
Heart Surgery
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Autologous Transfusion Products report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Autologous Transfusion Products are products that collect, process and preserve a patient's own blood for use in situations where a patient requires transfusion during surgery or other medical procedures. Compared with traditional donor blood, autologous blood transfusion products can avoid potential risks such as infection and immune reaction transmitted by donor blood, and can also reduce problems such as shortage of donor blood and cost of donor blood.
Global Autologous Transfusion Products market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Autologous Transfusion Products market research.
Key manufacturers engaged in the Autologous Transfusion Products industry include LivaNova, Haemonetics, Getinge AB, Medtronic, Terumo, Braile Biomedica, Fresenius Kabi, Appligent and Wandong Health Sources, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Autologous Transfusion Products were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Autologous Transfusion Products market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Autologous Transfusion Products market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
LivaNova
Haemonetics
Getinge AB
Medtronic
Terumo
Braile Biomedica
Fresenius Kabi
Appligent
Wandong Health Sources
Advancis Surgical
Macopharma SA
Asahi Kasei Medical
Stryker Corporation
Zimmer Biomet Holdings
Segment by Type
Intraoperative Autologous Transfusion Products
Postoperative Autologous Transfusion Products
Dual Mode Autologous Transfusion Products
Segment by Application
Organ Transplant Surgery
Orthopedic Surgery
Heart Surgery
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Autologous Transfusion Products report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Autologous Transfusion Products Market Overview
1.1 Product Overview and Scope of Autologous Transfusion Products
1.2 Autologous Transfusion Products Segment by Type
1.2.1 Global Autologous Transfusion Products Market Value Comparison by Type (2023-2029)
1.2.2 Intraoperative Autologous Transfusion Products
1.2.3 Postoperative Autologous Transfusion Products
1.2.4 Dual Mode Autologous Transfusion Products
1.3 Autologous Transfusion Products Segment by Application
1.3.1 Global Autologous Transfusion Products Market Value by Application: (2023-2029)
1.3.2 Organ Transplant Surgery
1.3.3 Orthopedic Surgery
1.3.4 Heart Surgery
1.3.5 Others
1.4 Global Autologous Transfusion Products Market Size Estimates and Forecasts
1.4.1 Global Autologous Transfusion Products Revenue 2018-2029
1.4.2 Global Autologous Transfusion Products Sales 2018-2029
1.4.3 Global Autologous Transfusion Products Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Autologous Transfusion Products Market Competition by Manufacturers
2.1 Global Autologous Transfusion Products Sales Market Share by Manufacturers (2018-2023)
2.2 Global Autologous Transfusion Products Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Autologous Transfusion Products Average Price by Manufacturers (2018-2023)
2.4 Global Autologous Transfusion Products Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Autologous Transfusion Products, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Autologous Transfusion Products, Product Type & Application
2.7 Autologous Transfusion Products Market Competitive Situation and Trends
2.7.1 Autologous Transfusion Products Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Autologous Transfusion Products Players Market Share by Revenue
2.7.3 Global Autologous Transfusion Products Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Autologous Transfusion Products Retrospective Market Scenario by Region
3.1 Global Autologous Transfusion Products Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Autologous Transfusion Products Global Autologous Transfusion Products Sales by Region: 2018-2029
3.2.1 Global Autologous Transfusion Products Sales by Region: 2018-2023
3.2.2 Global Autologous Transfusion Products Sales by Region: 2024-2029
3.3 Global Autologous Transfusion Products Global Autologous Transfusion Products Revenue by Region: 2018-2029
3.3.1 Global Autologous Transfusion Products Revenue by Region: 2018-2023
3.3.2 Global Autologous Transfusion Products Revenue by Region: 2024-2029
3.4 North America Autologous Transfusion Products Market Facts & Figures by Country
3.4.1 North America Autologous Transfusion Products Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Autologous Transfusion Products Sales by Country (2018-2029)
3.4.3 North America Autologous Transfusion Products Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Autologous Transfusion Products Market Facts & Figures by Country
3.5.1 Europe Autologous Transfusion Products Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Autologous Transfusion Products Sales by Country (2018-2029)
3.5.3 Europe Autologous Transfusion Products Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Autologous Transfusion Products Market Facts & Figures by Country
3.6.1 Asia Pacific Autologous Transfusion Products Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Autologous Transfusion Products Sales by Country (2018-2029)
3.6.3 Asia Pacific Autologous Transfusion Products Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Autologous Transfusion Products Market Facts & Figures by Country
3.7.1 Latin America Autologous Transfusion Products Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Autologous Transfusion Products Sales by Country (2018-2029)
3.7.3 Latin America Autologous Transfusion Products Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Autologous Transfusion Products Market Facts & Figures by Country
3.8.1 Middle East and Africa Autologous Transfusion Products Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Autologous Transfusion Products Sales by Country (2018-2029)
3.8.3 Middle East and Africa Autologous Transfusion Products Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Autologous Transfusion Products Sales by Type (2018-2029)
4.1.1 Global Autologous Transfusion Products Sales by Type (2018-2023)
4.1.2 Global Autologous Transfusion Products Sales by Type (2024-2029)
4.1.3 Global Autologous Transfusion Products Sales Market Share by Type (2018-2029)
4.2 Global Autologous Transfusion Products Revenue by Type (2018-2029)
4.2.1 Global Autologous Transfusion Products Revenue by Type (2018-2023)
4.2.2 Global Autologous Transfusion Products Revenue by Type (2024-2029)
4.2.3 Global Autologous Transfusion Products Revenue Market Share by Type (2018-2029)
4.3 Global Autologous Transfusion Products Price by Type (2018-2029)
5 Segment by Application
5.1 Global Autologous Transfusion Products Sales by Application (2018-2029)
5.1.1 Global Autologous Transfusion Products Sales by Application (2018-2023)
5.1.2 Global Autologous Transfusion Products Sales by Application (2024-2029)
5.1.3 Global Autologous Transfusion Products Sales Market Share by Application (2018-2029)
5.2 Global Autologous Transfusion Products Revenue by Application (2018-2029)
5.2.1 Global Autologous Transfusion Products Revenue by Application (2018-2023)
5.2.2 Global Autologous Transfusion Products Revenue by Application (2024-2029)
5.2.3 Global Autologous Transfusion Products Revenue Market Share by Application (2018-2029)
5.3 Global Autologous Transfusion Products Price by Application (2018-2029)
6 Key Companies Profiled
6.1 LivaNova
6.1.1 LivaNova Corporation Information
6.1.2 LivaNova Description and Business Overview
6.1.3 LivaNova Autologous Transfusion Products Sales, Revenue and Gross Margin (2018-2023)
6.1.4 LivaNova Autologous Transfusion Products Product Portfolio
6.1.5 LivaNova Recent Developments/Updates
6.2 Haemonetics
6.2.1 Haemonetics Corporation Information
6.2.2 Haemonetics Description and Business Overview
6.2.3 Haemonetics Autologous Transfusion Products Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Haemonetics Autologous Transfusion Products Product Portfolio
6.2.5 Haemonetics Recent Developments/Updates
6.3 Getinge AB
6.3.1 Getinge AB Corporation Information
6.3.2 Getinge AB Description and Business Overview
6.3.3 Getinge AB Autologous Transfusion Products Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Getinge AB Autologous Transfusion Products Product Portfolio
6.3.5 Getinge AB Recent Developments/Updates
6.4 Medtronic
6.4.1 Medtronic Corporation Information
6.4.2 Medtronic Description and Business Overview
6.4.3 Medtronic Autologous Transfusion Products Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Medtronic Autologous Transfusion Products Product Portfolio
6.4.5 Medtronic Recent Developments/Updates
6.5 Terumo
6.5.1 Terumo Corporation Information
6.5.2 Terumo Description and Business Overview
6.5.3 Terumo Autologous Transfusion Products Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Terumo Autologous Transfusion Products Product Portfolio
6.5.5 Terumo Recent Developments/Updates
6.6 Braile Biomedica
6.6.1 Braile Biomedica Corporation Information
6.6.2 Braile Biomedica Description and Business Overview
6.6.3 Braile Biomedica Autologous Transfusion Products Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Braile Biomedica Autologous Transfusion Products Product Portfolio
6.6.5 Braile Biomedica Recent Developments/Updates
6.7 Fresenius Kabi
6.6.1 Fresenius Kabi Corporation Information
6.6.2 Fresenius Kabi Description and Business Overview
6.6.3 Fresenius Kabi Autologous Transfusion Products Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Fresenius Kabi Autologous Transfusion Products Product Portfolio
6.7.5 Fresenius Kabi Recent Developments/Updates
6.8 Appligent
6.8.1 Appligent Corporation Information
6.8.2 Appligent Description and Business Overview
6.8.3 Appligent Autologous Transfusion Products Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Appligent Autologous Transfusion Products Product Portfolio
6.8.5 Appligent Recent Developments/Updates
6.9 Wandong Health Sources
6.9.1 Wandong Health Sources Corporation Information
6.9.2 Wandong Health Sources Description and Business Overview
6.9.3 Wandong Health Sources Autologous Transfusion Products Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Wandong Health Sources Autologous Transfusion Products Product Portfolio
6.9.5 Wandong Health Sources Recent Developments/Updates
6.10 Advancis Surgical
6.10.1 Advancis Surgical Corporation Information
6.10.2 Advancis Surgical Description and Business Overview
6.10.3 Advancis Surgical Autologous Transfusion Products Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Advancis Surgical Autologous Transfusion Products Product Portfolio
6.10.5 Advancis Surgical Recent Developments/Updates
6.11 Macopharma SA
6.11.1 Macopharma SA Corporation Information
6.11.2 Macopharma SA Autologous Transfusion Products Description and Business Overview
6.11.3 Macopharma SA Autologous Transfusion Products Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Macopharma SA Autologous Transfusion Products Product Portfolio
6.11.5 Macopharma SA Recent Developments/Updates
6.12 Asahi Kasei Medical
6.12.1 Asahi Kasei Medical Corporation Information
6.12.2 Asahi Kasei Medical Autologous Transfusion Products Description and Business Overview
6.12.3 Asahi Kasei Medical Autologous Transfusion Products Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Asahi Kasei Medical Autologous Transfusion Products Product Portfolio
6.12.5 Asahi Kasei Medical Recent Developments/Updates
6.13 Stryker Corporation
6.13.1 Stryker Corporation Corporation Information
6.13.2 Stryker Corporation Autologous Transfusion Products Description and Business Overview
6.13.3 Stryker Corporation Autologous Transfusion Products Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Stryker Corporation Autologous Transfusion Products Product Portfolio
6.13.5 Stryker Corporation Recent Developments/Updates
6.14 Zimmer Biomet Holdings
6.14.1 Zimmer Biomet Holdings Corporation Information
6.14.2 Zimmer Biomet Holdings Autologous Transfusion Products Description and Business Overview
6.14.3 Zimmer Biomet Holdings Autologous Transfusion Products Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Zimmer Biomet Holdings Autologous Transfusion Products Product Portfolio
6.14.5 Zimmer Biomet Holdings Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Autologous Transfusion Products Industry Chain Analysis
7.2 Autologous Transfusion Products Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Autologous Transfusion Products Production Mode & Process
7.4 Autologous Transfusion Products Sales and Marketing
7.4.1 Autologous Transfusion Products Sales Channels
7.4.2 Autologous Transfusion Products Distributors
7.5 Autologous Transfusion Products Customers
8 Autologous Transfusion Products Market Dynamics
8.1 Autologous Transfusion Products Industry Trends
8.2 Autologous Transfusion Products Market Drivers
8.3 Autologous Transfusion Products Market Challenges
8.4 Autologous Transfusion Products Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
